Literature DB >> 33552317

Endovascular treatment of middle cerebral artery aneurysms - single-centre results.

Paweł Brzegowy1, Jakub Polak2, Jakub Wnuk2, Bartłomiej Łasocha3, Borys Kwinta4, Andrzej Urbanik1, Tadeusz J Popiela1.   

Abstract

PURPOSE: The middle cerebral artery (MCA) is the second most common location of intracerebral aneurysms. Traditionally, they are treated by microsurgical clipping, but with the development of new techniques and devices endovascular embolisation is gaining more importance. The aim of this study was to summarise six years of experience of our department in endovascular treatment of MCA aneurysms.
MATERIAL AND METHODS: Forty patients with 41 MCA aneurysms treated in a single centre were included in this study. Data on patients' comorbidities, aneurysm morphology, and treatment course were collected, with special emphasis on complications.
RESULTS: There were no statistically significant differences in terms of aneurysm morphology between males and females and between ruptured and unruptured aneurysms. None of the diseases analysed in the current study were linked with significantly increased risk of SAH. Unruptured aneurysms were significantly more frequently treated by stent-assisted coiling (30.4% vs. 5.6%, p = 0.0388) than were ruptured aneurysms, while ruptured aneurysms were treated more frequently by coiling alone (77.8% vs. 34.8%, p = 0.0062). After an initial course of treatment 63.4% (n = 26) of patients had class I in Raymond-Roy occlusion classification, 22% (n = 9) had class II, and 14.6% (n = 6) had class III. Complications of the procedure were observed in 17.5% (n = 7) of patients: 22.2% (n = 4) with ruptured and 13.6% (n = 3) with unruptured aneurysms.
CONCLUSIONS: Endovascular treatment of MCA aneurysms is feasible, and our results are convergent with other studies. Ruptured MCA aneurysms may be treated endovascularly with similar effects as unruptured MCA aneurysms. The complication rate of such treatment is low. © Pol J Radiol 2020.

Entities:  

Keywords:  MCA aneurysm; endovascular treatment; stent-assisted coiling

Year:  2020        PMID: 33552317      PMCID: PMC7857335          DOI: 10.5114/pjr.2020.103204

Source DB:  PubMed          Journal:  Pol J Radiol        ISSN: 1733-134X


Introduction

The middle cerebral artery (MCA) is one of the most frequent locations of intracranial aneurysms (IA). Their share of IA ranges from 20 to 43% [1,2]. The basic approach to MCA aneurysm treatment is neurosurgical clipping, which is well established [3-6]. Moreover, ruptured MCA aneurysms usually require surgical treatment of the adjacent haematoma [7]. At the same time, endovascular therapy for MCA aneurysms is available, with the first study comparing MCA aneurysm clipping and endovascular treatment published in 1999 [4]. The endovascular treatment of intracranial aneurysms is developing rapidly. The role of the endovascular approach in MCA aneurysm treatment is constantly increasing, with new devices allowing for treatment of more complex aneurysms [7-10]. MCA aneurysms are considered challenging for endovascular treatment due to the anatomy of MCA and their localisation. The diameter of MCA is relatively small, and aneurysms often incorporate branches arising from MCA trunk. The choice of treatment method should be based on size, location, and neck size of the aneurysm, as well as comorbidities and patients’ age. The choice between clipping and endovascular procedure, as well as between different types of endovascular procedures, is crucial for the success of treatment. Intracranial aneurysms are the most common cause of subarachnoid haemorrhage (SAH). It often occurs in young patients and is the cause of loss of productive life years in the same rate as seen in cerebral stroke [11]. It is estimated that about 50% of patients with an SAH episode die and 20% suffer from its complications [12]. Advances in technology have led to an increase in the number of aneurysms treated by endovascular procedures. Nonetheless, more data are needed to support their quality and safety. The aim of this study was to summarise the eight years of experience of our department in endovascular treatment of MCA aneurysms, and to compare the results of treatment of ruptured and unruptured aneurysms.

Material and methods

After obtaining approval from the institutional Bioethics Committee, we retrospectively assessed all procedures of endovascular treatment of intracranial aneurysms from 2013 to 2018. All patients aged 18 years and older, who had undergone embolisation of MCA aneurysm, were included. Forty patients with 41 MCA aneurysms were treated. Eighteen (45%) men with 19 (46.3%) aneurysms were included in this group. Mean age of patients was 56.15 (± 13.86; range 25-92) years. In our group, 43.9% (n = 18) of patients had SAH due to MCA aneurysm rupture, while 56.1% (n = 23) were treated for unruptured aneurysms. The procedures were performed under general anaes-thesia with the use of a mono-plane Axiom Artis dFA angiography system equipped with 3D DSA and Dyna CT connected with workstation reconstruction software (Siemens Healthcare, Erlangen, Germany). In all patients who underwent the procedure, data on age and sex, neurological status (assessed with the Glasgow Coma Scale, Hunt-Hess scale, and World Fede-ration of Neurosurgical Societies scale), and incidence of subarachnoid haemorrhage were collected. The incidence of comorbidities, such as: hypertension, diabetes, ischaemic heart disease, hypercholesterolaemia, obesity, lung, kidney, and liver diseases, and history of myocardial infarction, ischaemic stroke, and subarachnoid haemorrhage was also evaluated. Next, aneurysm morphology was assessed based on three-dimensional digital subtraction angiography (3D DSA) studies. Two independent researchers measured the dimensions. Aneurysm shape, maximal height, maximal width, neck width, and inflow angle were determined. Aneurysm shape was defined as spherical if its height, width, and diameter perpendicular to its width were equal; ellipsoid if only the width and height were equal, and irregular if it could not be categorised into the previous groups. Then, morphological indexes, such as aspect ratio (AR), width-to-height ratio (WH), and bottleneck factor (BNF) and, using AngioCalc calculator (www.angiocalc.com), aneurysm volume and percentage packing volume were calculated. Inflow angle, defined as the angle between parent vessel and maximal height of the aneurysm dome was measured. To evaluate the aneurysm location, they were classified to four groups: in MCA bifurcation, in further branches, by lenticulostriate arteries and by early cortical branches. The M1 segment length was also measured. The treatment course was evaluated: number of endovascular procedures, recanalisation rate, type of endovascular procedure (coiling, balloon-assisted coiling, stent-assisted coiling, Y-stenting, flow diverter, pCONus), as well as the results of embolisation in the Raymond-Roy scale. The recorded complications included bleeding during procedure, relocation of coils during the procedure, formation of thrombus during the procedure, transfer to an intensive care unit, and death. Continuous variables were analysed using Student’s t-test or Mann-Whitney test, and categorical variables were analysed using chi-square analysis. In all analyses, p < 0.05 was considered statistically significant. All statistical analyses were performed using Statistica version 12.5 (StatSoft Inc., Tulsa, OK, USA).

Results

Morphology of aneurysms and middle cerebral artery

The localisation of the aneurysms is shown in Figure 1. Aneurysms in bifurcation of MCA were the most commonly treated. The morphological features of aneurysms are presented in Table 1. There were no statistically significant differences in terms of aneurysm morphology between males and females and between ruptured and unruptured aneurysms, although ruptured aneurysms tended to be larger. However, differences in M1 segment length were observed between patients with ruptured and unruptured aneurysms (13.3 ± 3.7 vs. 17.5 ± 6.3, p = 0.0155). M1 segment lengths ranged from 5.3 mm to 19.8 mm in patients with ruptured aneurysms and from 7.1 mm to 33.0 mm in patients with unruptured aneurysms. 42.5% (n = 17) of patients had multiple aneurysms. 32.4% (n = 10) had one additional aneurysm, 10% (n = 4) had two additional aneu-rysms, 2.5% (n = 1) had three additional aneurysms, and 5% (n = 2) had four additional aneurysms. 32.5% (n = 13) of patients had additional ipsilateral MCA aneurysms and 7.5% (n = 3) had mirror MCA bifurcation aneurysms.
Figure 1

Localization of treated middle cerebral artery aneurysms. ICA – internal carotid artery, LSA – lenticulostriatae arteries, ECB – early cortical branches

Table 1

Morphology of ruptured and unruptured aneurysms. All p >0.05

FactorAll aneurysmsRuptured aneurysmsUnruptured aneurysms
Aneurysm shape (%)
Spherical51.244.456.5
Ellipsoid24.427.821.7
Irregular24.427.821.7
Diameters (mm)
Neck width3.443.483.42
Maximal height4.034.503.90
Maximal width4.714.814.60
Width 23.954.663.80
AR1.151.241.13
WH1.141.231.31
BNF1.44 (± 0.52)1.57 (± 0.67)1.33 (± 0.35)
Other
Inflow angle (o)121.73 (± 32.29)125.52 (± 31.85)118.76 (± 33.04)
Volume (mm3)31.7769.4220.25
Localization of treated middle cerebral artery aneurysms. ICA – internal carotid artery, LSA – lenticulostriatae arteries, ECB – early cortical branches Morphology of ruptured and unruptured aneurysms. All p >0.05

Comorbidities

None of the diseases analysed in the current study were linked with significantly increased risk of SAH. Past history of SAH, ischaemic stroke, or myocardial infarction and family history of aneurysms were distributed equally in both groups. Tobacco smoking and alcohol use disorder did not correlate with the incidence of SAH.

Treatment method

In ruptured aneurysms, 15 patients were treated by coiling alone, two by balloon-assisted coiling, and one by stent-assisted coiling. In unruptured aneurysms, seven were treated by coiling alone, three by balloon-assisted coiling, 10 by stent assisted coiling (1 Y-stenting), two by flow diverter, and one by pCONus with coils. Three aneurysms treated with stents due to wide neck and high tortuosity of M2 MCA branches were treated with two-stage procedure. In total, 44 endovascular procedures were performed: 38 aneurysms were treated in a one-stage procedure, while three required a planned two-stage procedure. Five of the unruptured aneurysms were retreated due to recanalisation after surgical clipping (Figure 2A-D). Unruptured aneurysms were significantly more frequently treated by stent-assisted coiling (30.4% vs. 5.6%, p = 0.0388) than ruptured aneurysms, while ruptured aneurysms were treated more frequently by coiling alone (77.8% vs. 34.8%, p = 0.0062). No connection of morphological features and treatment method was found.
Figure 2

A) Recurrent left middle cerebral artery bifurcation aneurysm after surgical clipping. B-C) Y-stenting coil embolization. Follow-up contrast magnetic resonance angiography (MRA) shows total occlusion of the aneurysm and patency od LMCA branches (D)

A) Recurrent left middle cerebral artery bifurcation aneurysm after surgical clipping. B-C) Y-stenting coil embolization. Follow-up contrast magnetic resonance angiography (MRA) shows total occlusion of the aneurysm and patency od LMCA branches (D)

Immediate treatment results

After the initial course of treatment 63.4% (n = 26) of patients had class I aneurysms in Raymond-Roy occlusion classification, 22% (n = 9) had class II, and 14.6% (n = 6) had class III. Mean packing density was 26.20 ± 0.20%. No significant difference in packing density (30.6% vs. 20.8%; p = 0.2939) and class in Raymond-Roy occlusion classification (1.7 ± 0.8 vs. 1.4 ± 0.6; p = 0.2085) was detected between ruptured and unruptured aneurysms. No connection between treatment method and better outcomes was found.

Complications

Complications of the procedure were observed in 17.5% (n = 7 out of 40) of patients: 22.2% (n = 4 out of 18) with ruptured and 13.6% (n = 3 out of 22) with unruptured aneurysms (p = 0.48). Bleeding from the aneurysm during procedure occurred in 5% (n = 2) of patients. In one patient with SAH the bleeding, which appeared after aneurysm perforation during coil packing, was stopped by balloon inflation. In one patient unruptured aneurysm bleeding, which was a result of microwire perforation of aneurysm sac, was stopped by coil implantation. Relocation of coils into the lumen of the vessel occurred in 5% (n = 2) of patients without flow disturbances and thromboembolic events. Thromboembolic complications occurred in 5% (n = 2) of patients, both treated with balloon-assisted coiling. In one patient with ruptured aneurysm, mechanical thrombectomy of M1 occlusion was performed, but complete recanalisation was not achieved, and the patient died due to ischaemic changes. In the patient with unruptured aneurysm, asymptomatic ischaemic stroke in an area supplied by the branch originating from the aneurysm neck was detected in post-procedural CT three days after the procedure, with no neurological deficits. In 2.5% (n = 1) of patients, dissection of the internal carotid artery with no haemodynamic disturbances occurred, but it was complicated by persistent mild aphasia. Seven patients with SAH required hospitalisation in intensive care unit, and three of them died. Among patients with unruptured aneurysms none died. Aneurysm morphology, aneurysm rupture, method of endovascular treatment, packing density, and neurological state have been found not to be connected with increased risk of intra-procedural complications.

Follow-up

In 54% of patients (n = 20) diagnostic imaging follow-up (DSA, MRI and CT angiography studies) was available. The mean time of follow-up on diagnostic imaging was 1.6 ± 1.7 years. Recanalisation occurred in four patients (three with SAH and one without SAH). One unruptured and two ruptured aneurysms were retreated once due to recanalisation and one ruptured aneurysm had two treatments of recanalisation. Recanalisation of aneurysms was treated by coiling alone in one case, by stenting alone in one case, by stent-assisted coiling in two cases, and by pCONus with coils in one case. All treatments of recanalisation achieved class I in Raymond-Roy occlusion classification. Clinical follow-up 30 days after the procedure was available for eight patients, with six patients scoring 0 points on modified Rankin Scale (mRS), and two patients with 2 points on mRS. Delayed clinical follow-up was available for 16 patients, with a mean time of follow-up of 2.9 ± 2.4 years. Thirteen patients scored 0 points on mRS, two patients scored 1 point, and one patient scored 4 points, for the mean of 0.6 ± 1.2 points. The overall probability of any incident-free survival was 90.3%; in the group with SAH it was 80% and in the group without SAH 95.2%. The total probability of severe complications (intraprocedural bleeding and thromboembolic complications) was 20% (Figure 3).
Figure 3

Kaplan-Meier event-free survival courses for patients undergoing middle cerebral artery aneurysms endovascular treatment. Overall survival free any events (A) in patients with and without subarachnoid haemorrhage (B). Cumulative survival freedom for patients with complications – bleeding and thromboembolic events (C)

Kaplan-Meier event-free survival courses for patients undergoing middle cerebral artery aneurysms endovascular treatment. Overall survival free any events (A) in patients with and without subarachnoid haemorrhage (B). Cumulative survival freedom for patients with complications – bleeding and thromboembolic events (C)

Discussion

MCA aneurysms were considered challenging to treat by endovascular approach, probably due to the anatomy of MCA. Nearly 90% of MCA aneurysms are located in the M1 segment division; from 3.57% to 13.33% in distal M2 segment divisions [13]. Thus, aneurysms localised in the MCA trunk division may incorporate the enbranchnig vessel, which makes the procedure difficult [5]. Developments in imaging techniques allowed for better assessment of MCA anatomy and more appropriate use of adjunctive devices. The introduction of compliant balloons and self-expanding stents to clinical practice has changed the approach to wide-necked aneurysms. New devices that aim to increase the share of MCA aneurysms treated endovascularly are constantly being developed. Devices like pCONus (Phenox, Bochum, Germany) and PulseRider (Pulsar Vascular, Los Gatos, CA, USA) are used as an alternative to double-stenting methods to treat wide-necked aneurysms located in arterial bifurcations [14,15]. Two cases treated with pCONus are presented in this series. Another one is the Woven EndoBridge, an intraluminal device that is used as an alternative to coils [16]. Previously endovascular approach was also more likely to cause thromboembolic complications. Development of new anticoagulation treatments has largely contributed to limiting of those events [17]. A randomised trial points out that coiling may be more beneficial for patients with SAH in different localisations compared to microsurgical treatment [18]. However, it may differ in MCA aneurysms. Recent studies have shown that endovascular treatment may be a proper approach in MCA aneurysm treatment after considering neurosurgery [7]. The results of this study are similar to those previously published. The aneurysm morphology measurements showed no differences between ruptured and unruptured aneurysms. Ruptured aneurysms had a tendency to be larger (median volumes 20.25 vs. 69.42 mm3; p = 0.21), but this parameter differs between studies [19,20]. It may be due to the fact that most of the studies include rather limited series of MCA aneurysms. Kadkhodayan et al. demonstrated in their study with the largest series of 346 aneurysms that the mean size of ruptured aneurysm was significantly greater [21]. The median aneurysm neck width was 3.44 mm, which is similar to the results other studies [17,22]. Table 2 presents a comparison of recent studies concerning MCA aneurysms treatment. Our study also shows that M1 length can contribute to MCA aneurysm rupture. Haemodynamic factors are a known contributor to both aneurysm formation and rupture. No previous clinical study has found any correlation of M1 length and rupture of the aneurysm; however, M1 length has been proven to be associated with MCA aneurysm formation [23]. Further studies on a larger group of patients are needed to determine its clinical significance.
Table 2

Comparison of recent studies of endovascular treatment of middle cerebral artery aneurysms. RR1 – Raymond-Roy class I, RR2 – Raymond-Roy class II, RR3 – Raymond-Roy class III

ParametersThis studyLink et al. [17]Kadkhodayan et al. [24]Kim et al. [25]Abla et al. [26]
Demographic statistics
Mean age (years)56.15 (± 13.86)57 (± 15)56.7060.27 (± 10.77)
Males, n (%)18 (45)26 (27.96)95 (27.46)13 (43.33)10 (29.61)
Female, n (%)22 (55)67 (67.04)251 (72.54)17 (56.67)23 (69.70)
Number of aneurysms4194 (93 cured)346 (341 cured)3034
Aneurysm statistics
Ruptured, n (%)18 (43.90)40 (43.01)95 (27.46)3 (10)15 (44.12)
Unruptured, n (%)23 (56.10)53 (56.98)251 (72.54)27 (90)19 (55.88)
Retreatments, n (%)4 (9.76)6 (6.45)19 (5.49)7 (20.59)
Diameters (mm)
Maximal diameter4.71 (± 2.63)6.01 (± 2.73)6.610.55 (± 7.50)
Maximal neck width3.44 (± 1.64)3.25 (± 1.20)3.03.39 (± 1.41)
Aspect ratio1.15 (± 0.77)1.87 (± 0.61)3.18 (± 2.10)
Treatment method, n (%)
Coil embolisation22 (50.00)50 (53.76)86 (24.86)17 (56.80)21 (61.76)
Stent – assisted (stenting + stenting and coiling)14 (31.82)19 (20.43)26 (7.51)3 (10.00)11 (33.33)
Balloon assisted5 (11.36)24 (25.81)230 (66.47)2 (6.70)1 (3.00)
Other2 – flow diverter (4.55)1 – pCONus (2.27%)4 flow diversion pipeline (1.16)8 double microcatheter (26.70)2 ICA stenting (6.10)
Procedure outcomes, n (%)
RR126 (63.40)56 (60.21)324 (96.14) *complete or nearly complete28 (93.33) *complete10 (29.40)
RR29 (22.00)25 (26.88)15 (44.10)
RR36 (14.60)9 (9.67)13 (3.86)2 (6.67) *residual aneurysm7 (20.60)
Complications (intraprocedural), n (%)
TE and strokes2 (5.0)18 (19.35)47 (13.60)2 (6.67)4 (12.12)
Haemorrhages and aneurysm ruptures2 (5.0)2 (2.15)9 (2.60)07 (21.21)
Coil relocation2 (5.0)2 (2.15)1 (3.33)
Artery dissection1 (2.5)1 (1.08)02 (6.06)
Comparison of recent studies of endovascular treatment of middle cerebral artery aneurysms. RR1 – Raymond-Roy class I, RR2 – Raymond-Roy class II, RR3 – Raymond-Roy class III In 65% of patients complete occlusion of the aneurysm was achieved. Ruptured aneurysms were more difficult to occlude, but without statistical significance. These results were convergent with previous studies. Thromboembolic events are considered to be the most common complication during aneurysm coiling [27]. In our study thrombus formation occurred in 5% of cases. In other recent studies, thromboembolism seems to be a much more common complication. A comparison of complications is also presented in Table 2. Limitations of this study include its retrospective nature, limited group of patients, and long duration of observation, during which the devices used to perform the procedures were constantly changing.

Conclusions

Endovascular treatment of MCA aneurysms is feasible. Ruptured MCA aneurysms may be treated endovascularly with similar effects as unruptured MCA aneurysms. The complication rate of such treatment is low.
  26 in total

1.  Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001-2008.

Authors:  W Brinjikji; A A Rabinstein; D M Nasr; G Lanzino; D F Kallmes; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Endovascular treatment of middle cerebral artery aneurysms: A single center experience with a focus on thromboembolic complications.

Authors:  Thomas W Link; Srikanth R Boddu; Hoda T Hammad; Jared Knopman; Ning Lin; Pierre Gobin; Athos Patsalides
Journal:  Interv Neuroradiol       Date:  2017-10-31       Impact factor: 1.610

3.  Coil occlusion of wide-neck bifurcation aneurysms assisted by a novel intra- to extra-aneurysmatic neck-bridging device (pCONus): initial experience.

Authors:  M Aguilar-Pérez; W Kurre; S Fischer; H Bäzner; H Henkes
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-19       Impact factor: 3.825

4.  Middle cerebral artery anatomical variations and aneurysms: a retrospective study based on computed tomography angiography findings.

Authors:  P Brzegowy; J Polak; J Wnuk; B Łasocha; J Walocha; T J Popiela
Journal:  Folia Morphol (Warsz)       Date:  2017-12-13       Impact factor: 1.183

Review 5.  Middle cerebral artery extension and the risk for aneurysmal disease.

Authors:  Carlos Eduardo Gouvêa da Cunha; Carolina da Cunha Correia
Journal:  J Neurol Sci       Date:  2018-04-26       Impact factor: 3.181

Review 6.  Comparison of the Efficacy and Safety of Endovascular Coiling Versus Microsurgical Clipping for Unruptured Middle Cerebral Artery Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  Timothy R Smith; David J Cote; Hormuzdiyar H Dasenbrock; Youssef J Hamade; Samer G Zammar; Najib E El Tecle; H Hunt Batjer; Bernard R Bendok
Journal:  World Neurosurg       Date:  2015-06-18       Impact factor: 2.104

7.  Current management of middle cerebral artery aneurysms: surgical results with a "clip first" policy.

Authors:  Ana Rodríguez-Hernández; Michael E Sughrue; Sina Akhavan; Julian Habdank-Kolaczkowski; Michael T Lawton
Journal:  Neurosurgery       Date:  2013-03       Impact factor: 4.654

8.  Results of endovascular treatment of middle cerebral artery aneurysms after first giving consideration to clipping.

Authors:  Adib A Abla; Shady Jahshan; Peter Kan; Maxim Mokin; Travis M Dumont; Jorge L Eller; Kenneth V Snyder; L Nelson Hopkins; Adnan H Siddiqui; Elad I Levy
Journal:  Acta Neurochir (Wien)       Date:  2013-01-29       Impact factor: 2.216

9.  Size and location correlations with higher rupture risk of intracranial aneurysms.

Authors:  Cezary Grochowski; Jakub Litak; Bartłomiej Kulesza; Paweł Szmygin; Dominik Ziemianek; Piotr Kamieniak; Dariusz Szczepanek; Radosław Rola; Tomasz Trojanowski
Journal:  J Clin Neurosci       Date:  2017-10-31       Impact factor: 1.961

10.  Evolving role of endovascular treatment for MCA bifurcation aneurysms: case series of 184 aneurysms and review of the literature.

Authors:  Paula Eboli; Robert W Ryan; Julia E Alexander; Michael J Alexander
Journal:  Neurol Res       Date:  2014-02-18       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.